Table 2.

Correlation of in-person SPPB and virtual SPPB total and component scores with function and comorbidities (N=48)

ADLsIADLsComorbidity count
r95% CIr95% CIr95% CI
SPPB total 0.29 −0.04, 0.57 0.60 0.34, 0.80 −0.38 −0.64, −0.04 
SPPB strength 0.21 −0.10, 0.49 0.63 0.41, 0.80 −0.34 −0.57, −0.10 
SPPB balance 0.11 −0.22, 0.44 0.09 −0.29, 0.45 −0.16 −0.46, 0.20 
SPPB gait 0.46 0.16, 0.71 0.42 0.09, 0.68 −0.23 −0.46, 0.03 
vSPPB total 0.27 −0.02, 0.52 0.45 0.18, 0.67 −0.26 −0.49, 0.01 
vSPPB strength 0.32 0.05, 0.56 0.38 0.10, 0.62 −0.21 −0.44, 0.05 
vSPPB balance 0.27 −0.02, 0.53 0.34 0.03, 0.61 −0.12 −0.39, 0.16 
vSPPB gait 0.007 −0.30, 0.33 0.40 0.10, 0.66 −0.29 −0.50, −0.06 
ADLsIADLsComorbidity count
r95% CIr95% CIr95% CI
SPPB total 0.29 −0.04, 0.57 0.60 0.34, 0.80 −0.38 −0.64, −0.04 
SPPB strength 0.21 −0.10, 0.49 0.63 0.41, 0.80 −0.34 −0.57, −0.10 
SPPB balance 0.11 −0.22, 0.44 0.09 −0.29, 0.45 −0.16 −0.46, 0.20 
SPPB gait 0.46 0.16, 0.71 0.42 0.09, 0.68 −0.23 −0.46, 0.03 
vSPPB total 0.27 −0.02, 0.52 0.45 0.18, 0.67 −0.26 −0.49, 0.01 
vSPPB strength 0.32 0.05, 0.56 0.38 0.10, 0.62 −0.21 −0.44, 0.05 
vSPPB balance 0.27 −0.02, 0.53 0.34 0.03, 0.61 −0.12 −0.39, 0.16 
vSPPB gait 0.007 −0.30, 0.33 0.40 0.10, 0.66 −0.29 −0.50, −0.06 

Spearman correlation: 95% CI bootstrapped with 5000 resamples.

Comorbidities (range, 0-13; higher = more comorbid conditions).

ADL (range, 0-6; higher = more independent); and IADL (range, 0-14; higher = more independent).

View Large